The prevention of prostate cancer.

From our better understanding of the natural history of prostate cancer, it is not unreasonable to believe that the disease is preventable. Prostate cancer has become a major healthcare problem worldwide, as life expectancy increases. Moreover, the cancer is slow growing, with a period of about 20-25 years from initiation to the stage when the clinically detectable phenotype can be identified. This review provides a simple overview of the endocrinology of prostate cancer and discusses some of the pharmaceutical agents that have been or are being tested to restrain, possibly arrest, the progression of this slowly growing cancer. Also discussed are many of the dietary factors that may influence the molecular or endocrine events implicated in its development. Dietary factors are considered responsible for the geographical differences in prostate cancer incidence and mortality. Since about 50% of all men worldwide, from both East and West, show evidence of microscopic cancer by 50 years of age, growth restraint would appear to be the pragmatic option to the possibility of preventing initiation.

• Publication year

  2007

• Venue

  Recent results in cancer research. Fortschritte der Krebsforschung. Progres dans les recherches sur le cancer

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/978-3-540-40901-4_4PMID 17432553
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Prostate cancer prevention

  2013cited by this paper
• Prostate cancer prevention

  2007cited by this paper
• Molecular classification of green tea catechin-sensitive and green tea catechin-resistant prostate cancer in the TRAMP mice model by quantitative real-time PCR gene profiling.

  2006cited by this paper
• Chemoprevention of human prostate cancer by oral administration of green tea catechins in volunteers with high-grade prostate intraepithelial neoplasia: a preliminary report from a one-year proof-of-principle study.

  2006cited by this paper
• Meta-Analysis: High-Dosage Vitamin E Supplementation May Increase All-Cause Mortality

  2005cited by this paper
• Statin therapy for prevention and treatment of acute and chronic cardiovascular disease: update on recent trials and metaanalyses

  2005cited by this paper
• Impact of diet on prostate cancer: a review

  2005cited by this paper
• Increased Nox1 and hydrogen peroxide in prostate cancer

  2005cited by this paper
• Estimated impact of the Prostate Cancer Prevention Trial on population mortality

  2005cited by this paper
• Breast carcinoma chemoprevention in the community setting

  2005cited by this paper
• Meta‐analysis of soy food and risk of prostate cancer in men

  2005cited by this paper
• Dietary flavonols and flavonol‐rich foods intake and the risk of breast cancer

  2005cited by this paper
• Androgen receptor regulation by physiological concentrations of the isoflavonoid genistein in androgen-dependent LNCaP cells is mediated by estrogen receptor beta.

  2004cited by this paper
• Oral Consumption of Green Tea Polyphenols Inhibits Insulin-Like Growth Factor-I–Induced Signaling in an Autochthonous Mouse Model of Prostate Cancer

  2004cited by this paper
• Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties.

  2004cited by this paper
• Prostate cancer chemoprevention agent development: the National Cancer Institute, Division of Cancer Prevention portfolio.

  2004cited by this paper
• El estudio prospectivo europeo sobre cáncer y nutrición (EPIC)

  2004cited by this paper
• Protective effect of green tea against prostate cancer: A case‐control study in southeast China

  2004cited by this paper
• Prostate cancer – third international consultation on prostate cancer

  2004cited by this paper
• Prostate carcinogenesis in N-methyl-N-nitrosourea (NMU)-testosterone-treated rats fed tomato powder, lycopene, or energy-restricted diets.

  2004cited by this paper
• Estrogen Receptor in Prostate Cancer

  2004cited by this paper
• Examining the relationship between obesity and prostate cancer.

  2004cited by this paper
• Modulation of androgen receptor‐dependent transcription by resveratrol and genistein in prostate cancer cells

  2004cited by this paper
• Prostate carcinoma and green tea: PSA‐triggered basement membrane degradation and MMP‐2 activation are inhibited by (−)epigallocatechin‐3‐gallate

  2004cited by this paper
• Role of the stromal microenvironment in carcinogenesis of the prostate

  2003cited by this paper
• Estrogen signaling: a subtle balance between ER alpha and ER beta.

  2003cited by this paper
• Body mass index and risk of prostate cancer in U.S. health professionals.

  2003cited by this paper
• The influence of finasteride on the development of prostate cancer.

  2003cited by this paper
• Prostate cancer epidemiology.

  2003cited by this paper
• Soy isoflavonoid equol modulates the growth of benign and malignant prostatic epithelial cells in vitro

  2003cited by this paper
• Height, body mass index, and prostate cancer: a follow-up of 950 000 Norwegian men

  2003cited by this paper
• Body mass index in young adulthood and cancer mortality: a retrospective cohort study

  2002cited by this paper
• Apoptosis: target of cancer therapy.

  2002cited by this paper
• Determination of the isoflavonoids genistein and daidzein in biological samples by gas chromatography-mass spectrometry

  2002cited by this paper
• Androgen receptors in prostate cancer.

  2002cited by this paper
• Dietary fat reduction to reduce prostate cancer risk: controlled enthusiasm, learning a lesson from breast or other cancers, and the big picture.

  2002cited by this paper
• Resveratrol--a prostate cancer chemopreventive agent?

  2002cited by this paper
• Studies on prostatic cancer: I. The effect of castration, of estrogen and of androgen injection on serum phosphatases in metastatic carcinoma of the prostate. 1941.

  2002cited by this paper
• Prevalence and trends in obesity among US adults, 1999-2000.

  2002cited by this paper
• Large‐scale randomized prostate cancer screening trials: Program performances in the European randomized screening for prostate cancer trial and the prostate, lung, colorectal and ovary cancer trial

  2002cited by this paper
• Prostate cancer: another aspect of the insulin‐resistance syndrome?

  2002cited by this paper
• Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues.

  2002cited by this paper
• Toremifene prevents prostate cancer in the transgenic adenocarcinoma of mouse prostate model.

  2002cited by this paper
• A prospective study of tomato products, lycopene, and prostate cancer risk.

  2002cited by this paper
• Food, nutrition and the prevention of cancer : a global perspective

  2001cited by this paper
• Evidence that epithelial and mesenchymal estrogen receptor-alpha mediates effects of estrogen on prostatic epithelium.

  2001cited by this paper
• Carotenoids affect proliferation of human prostate cancer cells.

  2001cited by this paper
• Cyclooxygenase-2 is up-regulated in proliferative inflammatory atrophy of the prostate, but not in prostate carcinoma.

  2001cited by this paper
• Oestrogens, Phyto-oestrogens and the Pathogenesis of Prostatic Disease

  2001cited by this paper
• Energy balance and cancer: the role of insulin and insulin-like growth factor-I

  2001cited by this paper
• A role for estrogen receptor β in the regulation of growth of the ventral prostate

  2001cited by this paper
• The European Prospective Investigation into Cancer and Nutrition (EPIC): plans and progress.

  2001cited by this paper
• Similarities of prostate and breast cancer: Evolution, diet, and estrogens.

  2001cited by this paper
• Histological markers of risk and the role of high-grade prostatic intraepithelial neoplasia.

  2001cited by this paper
• The Soft Science of Dietary Fat

  2001cited by this paper
• Re: plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

  2001cited by this paper
• Chemoprevention: Increased potential to bear fruit

  2001cited by this paper
• Regulation of prostate growth

  2001cited by this paper
• Preneoplastic Prostate Lesions

  2001cited by this paper
• The role of molecular genetics in chemoprevention studies of prostate cancer.

  2001cited by this paper
• Plasma insulin-like growth factor-I, insulin-like growth factor-binding proteins, and prostate cancer risk: a prospective study.

  2000cited by this paper
• Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells

  2000cited by this paper
• Effect of Dietary Phytochemicals on Cancer Development

  2000cited by this paper
• Tomato lycopene and its role in human health and chronic diseases.

  2000cited by this paper
• Printed in U.S.A. Copyright © 2001 by The Endocrine Society The Metaplastic Effects of Estrogen on Mouse Prostate Epithelium: Proliferation of Cells with Basal

  2000cited by this paper
• Lycopene Interferes With Cell Cycle Progression and Insulin-Like Growth Factor I Signaling in Mammary Cancer Cells

  2000cited by this paper
• Selenium effects on prostate cell growth.

  2000cited by this paper
• Estrogens and prostatic disease

  2000cited by this paper
• Morphologic transitions between proliferative inflammatory atrophy and high-grade prostatic intraepithelial neoplasia.

  2000cited by this paper
• Plasma androgens, IGF-1, body size, and prostate cancer risk: a synthetic review

  2000cited by this paper
• Serum IGF-1 determination in relation to prostate cancer screening: possible differential diagnosis in relation to PSA assays

  2000cited by this paper
• International trends and patterns of prostate cancer incidence and mortality

  2000cited by this paper
• Role of the insulin-like growth factor family in cancer development and progression.

  2000cited by this paper
• Prostate cancer risk and prediagnostic serum 25-hydroxyvitamin D levels (Finland)

  2000cited by this paper
• Can alcohol promote aromatization of androgens to estrogens? A review.

  2000cited by this paper
• Neonatal Estrogen Exposure Alters the Transforming Growth Factor-β Signaling System in the Developing Rat Prostate and Blocks the Transient p21cip1/waf1 Expression Associated with Epithelial Differentiation.

  1999cited by this paper
• Dietary supplementation with n-3 polyunsaturated fatty acids and vitamin E after myocardial infarction: results of the GISSI-Prevenzione trial. Gruppo Italiano per lo Studio della Sopravvivenza nell'Infarto miocardico.

  1999cited by this paper
• Proliferative inflammatory atrophy of the prostate: implications for prostatic carcinogenesis.

  1999cited by this paper
• New insights into the interaction of Ras with the plasma membrane.

  1999cited by this paper
• β‐carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma

  1999cited by this paper
• Surrogate Endpoint Biomarkers for Clinical Trials of Prostate Cancer Chemoprevention

  1999cited by this paper
• Association of mis-sense substitution in SRD5A2 gene with prostate cancer in African-American and Hispanic men in Los Angeles, USA.

  1999cited by this paper
• Estrogen receptor expression in prostate cancer and premalignant prostatic lesions.

  1999cited by this paper
• The insulin-like growth factor axis and prostate cancer: lessons from the transgenic adenocarcinoma of mouse prostate (TRAMP) model.

  1999cited by this paper
• Tocotrienol: a review of its therapeutic potential.

  1999cited by this paper
• Dysregulation of apoptosis in cancer.

  1998cited by this paper
• Transcriptional Regulation of the Human Quinone Reductase Gene by Antiestrogen-liganded Estrogen Receptor-α and Estrogen Receptor-β*

  1998cited by this paper
• Naturally occurring oestrogens in food

  1998cited by this paper
• Controversy over diet to “prevent cancer”

  1998cited by this paper
• Linkage analysis of chromosome 1q markers in 136 prostate cancer families. The Cancer Research Campaign/British Prostate Group U.K. Familial Prostate Cancer Study Collaborators.

  1998cited by this paper
• Breast and prostate cancer: an analysis of common epidemiological, genetic, and biochemical features.

  1998cited by this paper
• Decreased incidence of prostate cancer with selenium supplementation: results of a double-blind cancer prevention trial.

  1998cited by this paper
• Effect of dietary phytochemicals on cancer development (review)

  1998cited by this paper
• Plasma Insulin-Like Growth Factor-I and Prostate Cancer Risk: A Prospective Study

  1998cited by this paper
• Prenylflavonoids: A New Class of Non-Steroidal Phytoestrogen (Part 2). Estrogenic Effects of 18-Isopentenylnaringenin on Bone Metabolism

  1998cited by this paper
• Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer.

  1998cited by this paper
• Children in cars

  1997cited by this paper
• Lycopene and myocardial infarction risk in the EURAMIC Study.

  1997cited by this paper
• Broccoli sprouts: an exceptionally rich source of inducers of enzymes that protect against chemical carcinogens.

  1997cited by this paper
• Response of cell growth and retinoic acid receptor expression to retinoic acid in neoplastic and non‐neoplastic prostate cell lines

  1997cited by this paper

• Prostate cancer risk reduction: promising prevention practices and insights

  2025cites this paper
• Enhanced Chemoprevention of Prostate Cancer by Combining Arctigenin with Green Tea and Quercetin in Prostate-Specific Phosphatase and Tensin Homolog Knockout Mice

  2024cites this paper
• Arctigenin inhibits prostate tumor growth in high-fat diet fed mice through dual actions on adipose tissue and tumor

  2020cites this paper
• Combinatorial Drug Therapy with Phytochemicals as Adjuvants in Prostate Cancer Management

  2019cites this paper
• Arctigenin inhibits prostate tumor cell growth in vitro and in vivo.

  2017cites this paper
• Oxidative stress in prostate hyperplasia and carcinogenesis

  2016cites this paper
• Arctigenin in combination with quercetin synergistically enhances the antiproliferative effect in prostate cancer cells.

  2015cites this paper
• Increased chemopreventive effect by combining arctigenin, green tea polyphenol and curcumin in prostate and breast cancer cells.

  2014cites this paper
• Expression of a Y-located human proto-oncogene TSPY in a transgenic mouse model of prostate cancer

  2014cites this paper
• Effect of antioxidant supplement on performance in rowers

  2013cites this paper
• Protective effect of γ‐tocopherol‐enriched diet on N‐methyl‐N‐nitrosourea‐induced epithelial dysplasia in rat ventral prostate

  2013cites this paper
• Mechanisms of Prostate Tumor Initiation: Interplay of Antioxidants and Genetic Alterations

  2013cites this paper
• Do No Harm: A Case in Point

  2012cites this paper
• Vascular endothelial growth factor and prostate cancer

  2011cites this paper
• Endocrine Approaches in the Therapy of Prostate Carcinoma

  2011cites this paper
• Nutrigenetics and Prostate Cancer: 2011 and Beyond

  2011influential citation